THORATEC CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-11-05: Form 8-K; Period of report 2014-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-10-06: Form 8-K; Period of report 2014-10-04; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2014-09-22: Form 8-K; Period of report 2014-09-16; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 5.02.
- 2014-08-06: Form 8-K; Period of report 2014-08-06; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-11-05 | 8-K | 2014-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2014, Thoratec Corporation (the “Company”) issued a press release announcing its third quarter ended September 27, 2014 results, the text of which is attached hereto as Exhibit 99.1. | v393286_8k.htm |
| 2014-10-06 | 8-K | 2014-10-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 6, 2014, Thoratec Corporation (the “Company”) issued a press release announcing the hiring of Niamh Pellegrini, age 48, to serve as the Company’s President, North America, effective October 13, 2014. | a14-21975_18k.htm |
| 2014-09-22 | 8-K | 2014-09-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.02 (b) Gary F. Burbach has stepped down from the the Board of Directors (the “Board”) of Thoratec Corporation (“Thoratec” or the “Company”) and from his position as President and Chief Executive Officer of the Company, effective September 22, 2014. 5.03 On September 16, 2014, the Board approved and adopted an amended and restated version of the Company’s bylaws (the “Amended Bylaws”). | a14-21222_18k.htm |
| 2014-08-06 | 8-K | 2014-08-06 | 2.02 Results of Operations and Financial Condition | 2.02 On August 6, 2014, Thoratec Corporation (the “Company”) issued a press release announcing its second quarter ended June 28, 2014 results, the text of which is attached hereto as Exhibit 99.1. | v385902_8k.htm |
| 2014-07-02 | 8-K | 2014-07-02 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On July 2, 2014, Thoratec issued a press release announcing that it had entered into the Purchase Agreements and consummated the Acquisition. | a14-16416_18k.htm |
| 2014-05-27 | 8-K | 2014-05-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 On May 22, 2014, Thoratec Corporation (the “Company”) hired Vasant Padmanabhan, PhD, as Senior Vice President, Technical Operations. 5.07 At the Thoratec Corporation (the “Company”) Annual Meeting of Shareholders held on May 21, 2014 (the “Annual Meeting”), the shareholders of the Company voted on the following six proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on April 9, 2014 and the supplement to proxy statement filed with the SEC on May 12, 2014. | a14-13612_18k.htm |
| 2014-05-06 | 8-K | 2014-05-06 | 2.02 Results of Operations and Financial Condition | 2.02 On May 6, 2014, Thoratec Corporation (the “Company”) issued a press release announcing its first quarter ended March 29, 2014 results, the text of which is attached hereto as Exhibit 99.1. | v377460_8k.htm |
| 2014-03-27 | 8-K | 2014-03-27 | 7.01 Regulation FD Disclosure | 7.01 As of the quarter ending March 29, 2014, the Company will no longer include PVAD and IVAD pump unit sales as part of quarterly pump unit disclosure. | a14-9058_18k.htm |
| 2014-03-18 | 8-K | 2014-03-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 13, 2014, Daniel M. Mulvena informed the Board of Directors (the “Board”) of Thoratec Corporation (the “Company”), that he has decided to retire from the Board after seventeen years of service and accordingly he will not stand for re-election to the Board. | a14-8137_18k.htm |
| 2014-03-04 | 8-K | 2014-03-04 | 7.01 Regulation FD Disclosure | 7.01 On Tuesday, March 4, 2014, Thoratec Corporation (“Thoratec” or the “Company”) issued a press release, which is furnished herewith as Exhibit 99.1, regarding the initiation of a voluntary worldwide medical device correction notification relating to the HeartMate II® LVAS Pocket System Controller. | a14-7256_18k.htm |
| 2014-02-04 | 8-K | 2014-02-04 | 2.02 Results of Operations and Financial Condition | 2.02 On February 4, 2014, Thoratec Corporation (the “Company”) issued a press release announcing its fourth quarter ended December 28, 2013 results, the text of which is attached hereto as Exhibit 99.1. | v367164_8k.htm |